BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34706365)

  • 1. Concordance of Cytological Specimens with Histological Tissue for Detection of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Systematic Review.
    Chua TH; Chuah KL
    Acta Cytol; 2022; 66(1):61-71. PubMed ID: 34706365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
    Wu CY; Hou LK; Ren SX; Su B; Chen G
    Asian Pac J Cancer Prev; 2014; 15(18):7885-9. PubMed ID: 25292082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer.
    Satoh Y; Matsuo Y; Kuba T; Yamashita K; Sawano M; Tozaka S; Yamazaki H; Sonoda D; Mikubo M; Naito M; Matsui Y; Shiomi K; Yoshida T; Murakumo Y
    Virchows Arch; 2020 May; 476(5):753-762. PubMed ID: 31823000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid-based cytology for lung cancer at bronchoscopic examinations.
    Tanaka R; Ohtsuka K; Ogura W; Arai N; Yoshida T; Nakazato Y; Tachibana K; Takata S; Fujiwara M; Kamma H; Shibahara J; Kondo H
    Diagn Cytopathol; 2020 Jun; 48(6):516-523. PubMed ID: 32125777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.
    Magnini D; Fuso L; Varone F; D'Argento E; Martini M; Pecoriello A; Di Noia V; Arciuolo D; Fadda G; Rindi G; Richeldi L
    Mol Diagn Ther; 2018 Dec; 22(6):723-728. PubMed ID: 30276554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
    Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
    Sun PL; Jin Y; Kim H; Lee CT; Jheon S; Chung JH
    Cancer Cytopathol; 2013 Jun; 121(6):311-9. PubMed ID: 23225576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience.
    Son C; Kang EJ; Roh MS
    Diagn Cytopathol; 2015 Jul; 43(7):532-8. PubMed ID: 25427228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
    Mohar B; Smojver Ježek S; Rajković Molek K; Štemberger C; Kurpis M; Kupanovac Ž; Samaržija M; Jonjić N; Grahovac B
    Cytopathology; 2016 Dec; 27(6):444-451. PubMed ID: 26990359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
    Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
    Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
    Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.
    Savic S; Tapia C; Grilli B; Rufle A; Bihl MP; de Vito Barascud A; Herzog M; Terracciano L; Baty F; Bubendorf L
    Br J Cancer; 2008 Jan; 98(1):154-60. PubMed ID: 18087280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?
    Vigliar E; Malapelle U; Bellevicine C; de Luca C; Troncone G
    Cytopathology; 2015 Oct; 26(5):312-7. PubMed ID: 25376259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.
    Liu CH; Chang SJ; Tsai MJ; Yang SF
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma.
    Ekin Z; Nart D; Savaş P; Veral A
    Balkan Med J; 2021 Sep; 38(5):287-295. PubMed ID: 34558414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens.
    Liu J; Zhao R; Zhang J; Zhang J
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):221-7. PubMed ID: 25156817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample features associated with success rates in population-based EGFR mutation testing.
    Shiau CJ; Babwah JP; da Cunha Santos G; Sykes JR; Boerner SL; Geddie WR; Leighl NB; Wei C; Kamel-Reid S; Hwang DM; Tsao MS
    J Thorac Oncol; 2014 Jul; 9(7):947-956. PubMed ID: 24922009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
    Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
    Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Preservations of Cytological Materials Using Liquid-Based Cytology Fixatives for Next-Generation Sequencing Analysis.
    Tanaka R; Fujiwara M; Nakazato Y; Arai N; Tachibana K; Sakamoto N; Kishimoto K; Kamma H; Shibahara J; Kondo H
    Acta Cytol; 2022; 66(5):457-465. PubMed ID: 35413709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
    da Cunha Santos G; Saieg MA
    Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.